• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型5-((3-(三氟甲基)哌啶-1-基)磺酰基)吲哚啉-2,3-二酮衍生物作为有前景的抗病毒药物的设计与合成:体外、计算机模拟及构效关系研究

Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure-Activity Relationship Studies.

作者信息

Ezz Eldin Rogy R, Saleh Marwa A, Alwarsh Sefat A, Rushdi Areej, Althoqapy Azza Ali, El Saeed Hoda S, Abo Elmaaty Ayman

机构信息

Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt.

Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11651, Egypt.

出版信息

Pharmaceuticals (Basel). 2023 Sep 4;16(9):1247. doi: 10.3390/ph16091247.

DOI:10.3390/ph16091247
PMID:37765055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10534365/
Abstract

Herein, a series of new isatin derivatives was designed and synthesized (-) as broad-spectrum antiviral agents. Consequently, the antiviral activities of the synthesized compounds (-) were pursued against three viruses, namely influenza virus (H1N1), herpes simplex virus 1 (HSV-1), and coxsackievirus B3 (COX-B3). In particular, compounds , , and displayed the highest antiviral activity against H1N1, HSV-1, and COX-B3 with IC values of 0.0027, 0.0022, and 0.0092 µM, respectively. Compound was the safest, with a CC value of 315,578.68 µM. Moreover, a quantitative PCR (real-time PCR) assay was carried out for the most relevant compounds. The selected compounds exhibited a decrease in viral gene expression. Additionally, the conducted in silico studies emphasized the binding affinities of the synthesized compounds and their reliable pharmacokinetic properties as well. Finally, a structure-antiviral activity relationship study was conducted to anticipate the antiviral activity change upon future structural modification.

摘要

在此,设计并合成了一系列新型异吲哚酮衍生物作为广谱抗病毒剂。因此,研究了合成化合物对三种病毒的抗病毒活性,即甲型流感病毒(H1N1)、单纯疱疹病毒1型(HSV-1)和柯萨奇病毒B3型(COX-B3)。特别是,化合物 、 和 对H1N1、HSV-1和COX-B3表现出最高的抗病毒活性,IC值分别为0.0027、0.0022和0.0092 μM。化合物 是最安全的,CC值为315,578.68 μM。此外,对最相关的化合物进行了定量PCR(实时PCR)分析。所选化合物的病毒基因表达有所下降。此外,所进行的计算机模拟研究强调了合成化合物的结合亲和力及其可靠的药代动力学性质。最后,进行了结构-抗病毒活性关系研究,以预测未来结构修饰后抗病毒活性的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/f7dcf80e63af/pharmaceuticals-16-01247-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/d08bc766f798/pharmaceuticals-16-01247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/01634709800d/pharmaceuticals-16-01247-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/e1e163a57be7/pharmaceuticals-16-01247-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/7065d6f8103e/pharmaceuticals-16-01247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/7d378efd4819/pharmaceuticals-16-01247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/4c9f67d52cde/pharmaceuticals-16-01247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/5950f75db3f1/pharmaceuticals-16-01247-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/52779e77680a/pharmaceuticals-16-01247-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/bf5a1b33fb6b/pharmaceuticals-16-01247-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/9bc6ccdaab86/pharmaceuticals-16-01247-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/53a5df9e6663/pharmaceuticals-16-01247-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/f7dcf80e63af/pharmaceuticals-16-01247-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/d08bc766f798/pharmaceuticals-16-01247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/01634709800d/pharmaceuticals-16-01247-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/e1e163a57be7/pharmaceuticals-16-01247-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/7065d6f8103e/pharmaceuticals-16-01247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/7d378efd4819/pharmaceuticals-16-01247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/4c9f67d52cde/pharmaceuticals-16-01247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/5950f75db3f1/pharmaceuticals-16-01247-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/52779e77680a/pharmaceuticals-16-01247-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/bf5a1b33fb6b/pharmaceuticals-16-01247-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/9bc6ccdaab86/pharmaceuticals-16-01247-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/53a5df9e6663/pharmaceuticals-16-01247-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10534365/f7dcf80e63af/pharmaceuticals-16-01247-g010.jpg

相似文献

1
Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure-Activity Relationship Studies.新型5-((3-(三氟甲基)哌啶-1-基)磺酰基)吲哚啉-2,3-二酮衍生物作为有前景的抗病毒药物的设计与合成:体外、计算机模拟及构效关系研究
Pharmaceuticals (Basel). 2023 Sep 4;16(9):1247. doi: 10.3390/ph16091247.
2
Anti-herpes simplex virus type 1 activity of the Rohdea chinensis (Baker) N. Tanaka aqueous extracts.万年青(贝克)田中新 aqueous 提取物的抗 1 型单纯疱疹病毒活性。
J Ethnopharmacol. 2025 Jun 26;350:120024. doi: 10.1016/j.jep.2025.120024. Epub 2025 May 22.
3
RETRACTED: Ezz Eldin et al. Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure-Activity Relationship Studies. 2023, , 1247.撤回:埃兹·埃尔丁等人。新型5-((3-(三氟甲基)哌啶-1-基)磺酰基)吲哚啉-2,3-二酮衍生物的设计与合成作为有前景的抗病毒药物:体外、计算机模拟和构效关系研究。2023年,,1247。
Pharmaceuticals (Basel). 2025 Feb 7;18(2):226. doi: 10.3390/ph18020226.
4
Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review.药用植物抗 HIV、HSV、流感、肝炎和柯萨奇病毒的抗病毒潜力:系统评价。
Phytother Res. 2018 May;32(5):811-822. doi: 10.1002/ptr.6024. Epub 2018 Jan 22.
5
Antiviral efficacy of hexane extract of Hypericum gaitii Haines against Chikungunya and SARS-CoV-2 viruses: in vitro and in silico approaches.盖氏金丝桃己烷提取物对基孔肯雅病毒和新型冠状病毒2的抗病毒效力:体外和计算机模拟方法
J Ethnopharmacol. 2025 Jul 10;353(Pt A):120270. doi: 10.1016/j.jep.2025.120270.
6
Targeting HSV-1 glycoprotein D through riboflavin-mediated photodynamic therapy: Insights from bioinformatics analysis and in vitro evaluation.通过核黄素介导的光动力疗法靶向单纯疱疹病毒1型糖蛋白D:来自生物信息学分析和体外评估的见解
Photodiagnosis Photodyn Ther. 2025 Aug;54:104683. doi: 10.1016/j.pdpdt.2025.104683. Epub 2025 Jun 13.
7
Aster tataricus extract and its active compounds display a broad spectrum of antiviral activity in vitro and in vivo.紫菀提取物及其活性化合物在体外和体内均表现出广泛的抗病毒活性。
Chin Med. 2025 Jul 15;20(1):113. doi: 10.1186/s13020-025-01167-1.
8
In vitro antiviral activities of thymol and Limonin against influenza a viruses and SARS-CoV-2.百里香酚和柠檬苦素对甲型流感病毒和严重急性呼吸综合征冠状病毒2的体外抗病毒活性。
Sci Rep. 2025 Jul 2;15(1):22587. doi: 10.1038/s41598-025-06967-x.
9
Novel pyrazole carboxylate derivatives as lonazolac bioisosteres with selective COX-2 inhibition: design, synthesis and anti-inflammatory activity.新型吡唑羧酸酯衍生物作为洛那唑酸生物电子等排体具有选择性COX-2抑制作用:设计、合成及抗炎活性
Mol Divers. 2025 May 22. doi: 10.1007/s11030-025-11220-8.
10
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.免疫功能正常的非妊娠患者预防生殖器疱疹发作的口服抗病毒治疗。
Cochrane Database Syst Rev. 2014 Aug 3;2014(8):CD009036. doi: 10.1002/14651858.CD009036.pub2.

引用本文的文献

1
RETRACTED: Ezz Eldin et al. Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure-Activity Relationship Studies. 2023, , 1247.撤回:埃兹·埃尔丁等人。新型5-((3-(三氟甲基)哌啶-1-基)磺酰基)吲哚啉-2,3-二酮衍生物的设计与合成作为有前景的抗病毒药物:体外、计算机模拟和构效关系研究。2023年,,1247。
Pharmaceuticals (Basel). 2025 Feb 7;18(2):226. doi: 10.3390/ph18020226.
2
Advances in quinoxaline derivatives: synthetic routes and antiviral efficacy against respiratory pathogens.喹喔啉衍生物的研究进展:合成路线及对呼吸道病原体的抗病毒疗效
RSC Adv. 2024 Nov 7;14(48):35400-35423. doi: 10.1039/d4ra04292a. eCollection 2024 Nov 4.
3

本文引用的文献

1
Bottom-up assembly of viral replication cycles.病毒复制周期的自下而上组装。
Nat Commun. 2022 Nov 2;13(1):6530. doi: 10.1038/s41467-022-33661-7.
2
Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies.基于结构的 3-(7-硝基-3-氧代-3,4-二氢喹喔啉-2-基)丙酰肼衍生物的设计与合成:作为新型细菌拓扑异构酶 II 抑制剂的体外、体内、计算和 SAR 研究。
Bioorg Chem. 2022 Dec;129:106186. doi: 10.1016/j.bioorg.2022.106186. Epub 2022 Oct 5.
3
Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies.
Identification of dual-target isoxazolidine-isatin hybrids with antidiabetic potential: Design, synthesis, and multiscale molecular modeling approaches.具有抗糖尿病潜力的双靶点异恶唑烷-异吲哚酮杂化物的鉴定:设计、合成及多尺度分子建模方法
Heliyon. 2024 Feb 11;10(4):e25911. doi: 10.1016/j.heliyon.2024.e25911. eCollection 2024 Feb 29.
新型苯并氮杂蒽酮衍生物作为潜在的CBSIs和凋亡诱导剂的设计与合成:体外、体内、分子对接、分子动力学及构效关系研究
Bioorg Chem. 2022 Oct;127:105995. doi: 10.1016/j.bioorg.2022.105995. Epub 2022 Jun 30.
4
Insighting isatin derivatives as potential antiviral agents against NSP3 of COVID-19.洞察异吲哚酮衍生物作为抗COVID-19非结构蛋白3的潜在抗病毒药物。
Chem Zvesti. 2022;76(10):6271-6285. doi: 10.1007/s11696-022-02298-7. Epub 2022 Jun 22.
5
Investigating the structure-activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors.研究海洋天然聚酮化合物作为有前景的新型冠状病毒主要蛋白酶抑制剂的构效关系。
RSC Adv. 2021 Sep 22;11(50):31339-31363. doi: 10.1039/d1ra05817g. eCollection 2021 Sep 21.
6
β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, , , and SAR studies for lead optimization.以羟乙胺和羟乙烯为潜在的新型冠状病毒主蛋白酶抑制剂的β-阻滞剂:基于合理设计及构效关系研究进行先导化合物优化
RSC Adv. 2021 Nov 3;11(56):35536-35558. doi: 10.1039/d1ra04820a. eCollection 2021 Oct 28.
7
Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and insights.丹参酮IIA、鼠尾草酸、迷迭香酸、丹酚酸、黄芩素和甘草次酸在计算和深入研究方面的抗SARS-CoV-2活性。
RSC Adv. 2021 Sep 1;11(47):29267-29286. doi: 10.1039/d1ra05268c.
8
Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study.重新审视某些糖皮质激素作为严重急性呼吸综合征冠状病毒2主要蛋白酶潜在抑制剂的活性:理论研究
RSC Adv. 2021 Mar 9;11(17):10027-10042. doi: 10.1039/d0ra10674g. eCollection 2021 Mar 5.
9
Enteroviral replication inhibition by N-Alkyl triazolopyrimidinone derivatives through a non-capsid binding mode.通过非衣壳结合模式抑制肠道病毒复制的 N-烷基三唑并嘧啶酮衍生物。
Bioorg Med Chem Lett. 2022 May 15;64:128673. doi: 10.1016/j.bmcl.2022.128673. Epub 2022 Mar 12.
10
Isatin derivatives as broad-spectrum antiviral agents: the current landscape.作为广谱抗病毒药物的异吲哚酮衍生物:当前概况
Med Chem Res. 2022;31(2):244-273. doi: 10.1007/s00044-021-02832-4. Epub 2022 Jan 13.